三大业务全版图首次齐聚进博，“凯西中国马可·波罗计划”再升级
Zhong Guo Xin Wen Wang·2025-11-11 01:51

Core Insights - Kaisi China announced the upgrade of the "Marco Polo Program" to version 3.0 at the 8th China International Import Expo, emphasizing its commitment to enhancing medical accessibility and advocating for healthcare equity [1][9] - The company aims to deepen collaborations with various partners, including JD Health and the China Rare Disease Alliance, to expand its ecosystem and improve patient care [1][7] Group 1: Strategic Collaborations - Kaisi signed a strategic cooperation agreement with JD Health, allowing the full line of respiratory products to be available on JD Health, focusing on disease education, online consultations, and chronic disease management [3] - Kaisi and Shangyao Cloud Health announced an upgraded strategic partnership to enhance outpatient services through "Yiyao Pharmacy," providing comprehensive health management for respiratory diseases [5] - A memorandum of cooperation was signed with the China Rare Disease Alliance to improve rare disease management and establish standardized treatment systems [7] Group 2: Product Innovations and Market Expansion - Kaisi showcased its innovative respiratory product, the inhalation powder aerosol, at the expo, aiming to provide new treatment options for asthma patients in China [10] - The company introduced nine innovative rare disease drugs, including FILSUVEZ®, which is the first approved treatment for certain genetic skin disorders, highlighting its commitment to addressing unmet medical needs [10] - Kaisi's "CARE" specialty treatment area has already helped 1.38 million premature infants in China, demonstrating its impact on public health [9] Group 3: Commitment to Healthcare Equity - Kaisi emphasizes the importance of medical equity and has initiated various programs to enhance awareness and treatment options for premature infants and respiratory diseases [9][10] - The company aims to leverage the "spillover effect" of the Import Expo to accelerate the introduction of innovative products and improve accessibility for patients [11]